Corinne John

Redbiotec AG develops and produces multi protein assemblies. It specializes in producing virus-like particles, various types of protein complexes and single proteins and VLP-based vaccines against various infectious diseases. The firms products are used in complex drug target, structural studies, target validation, antibody generation, biopharmaceutical and VLP applications. The company was founded in 2006 by Christian Schaub and Corinne John and is headquartered in Schlieren, Switzerland.

Redbiotec AG develops and produces multi protein assemblies. It specializes in producing virus-like particles, various types of protein complexes and single proteins and VLP-based vaccines against various infectious diseases. The firms products are used in complex drug target, structural studies, target validation, antibody generation, biopharmaceutical and VLP applications. The company was founded in 2006 by Christian Schaub and Corinne John and is headquartered in Schlieren, Switzerland.

Redbiotec AG develops and produces multi protein assemblies. It specializes in producing virus-like particles, various types of protein complexes and single proteins and VLP-based vaccines against various infectious diseases. The firms products are used in complex drug target, structural studies, target validation, antibody generation, biopharmaceutical and VLP applications. The company was founded in 2006 by Christian Schaub and Corinne John and is headquartered in Schlieren, Switzerland.

Redbiotec AG develops and produces multi protein assemblies. It specializes in producing virus-like particles, various types of protein complexes and single proteins and VLP-based vaccines against various infectious diseases. The firms products are used in complex drug target, structural studies, target validation, antibody generation, biopharmaceutical and VLP applications. The company was founded in 2006 by Christian Schaub and Corinne John and is headquartered in Schlieren, Switzerland.

Redbiotec AG develops and produces multi protein assemblies. It specializes in producing virus-like particles, various types of protein complexes and single proteins and VLP-based vaccines against various infectious diseases. The firms products are used in complex drug target, structural studies, target validation, antibody generation, biopharmaceutical and VLP applications. The company was founded in 2006 by Christian Schaub and Corinne John and is headquartered in Schlieren, Switzerland.